Chattem Inc.
1715 West 38th Street
Chattanooga,
TN 37409
United States - Map
Phone: 423-821-4571
Fax: 423-821-0395
Web Site: http://www.chattem.com
| Chattem, Inc., together with its subsidiaries, engages in the manufacture and marketing of over-the-counter (OTC) healthcare products, toiletries, and dietary supplements. The company markets its products under various brand names in categories, such as medicated skin care, topical pain care, oral care, internal OTC, medicated dandruff shampoos, dietary supplements, and other OTC and toiletry products. It sells medicated skin care products under the brands Gold Bond, Cortizone-10, and Balmex; topical pain care products under the Icy Hot, Aspercreme, Flexall, Capzasin, Sportscreme, and Arthritis Hot brand names; oral care products under the brands ACT, Herpecin-L, and Benzodent; and internal OTC products under the Pamprin, Premsyn PMS, Unisom, and Kaopectate brand names. The company also offers medicated dandruff shampoos under the brands Selsun Blue, Selsun Salon, and Selsun Natural; dietary supplement products under the Dexatrim, Garlique, Melatonex, New Phase, and Omnigest EZ brand names; and other OTC and toiletry products under the brands Bullfrog, Sun-In, UltraSwim, and Mudd. Chattem markets its products to mass merchandisers, and drug and food retailers in the United States, Canada, Peru, and Europe. The company was founded in 1879 and is headquartered in Chattanooga, Tennessee. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Zan Guerry , 60
Chairman and Chief Exec. Officer |
$
1.22M |
$
2.97M | Mr. Robert E. Bosworth , 61
Pres, Chief Operating Officer |
$
754.00K |
$
533.00K | Mr. Robert B. Long , 37
Chief Financial Officer and VP |
$
243.00K |
$
0 | Mr. Theodore K. Whitfield Jr., 44
Vice-Pres, Sec. and Gen. Counsel |
$
242.00K |
$
426.00K | Mr. Ron Galante , 65
VP of New Bus. Devel. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.16% Nasdaq 
0.37 (0.55%) 
Profile
